Category | Insight journal

Reckitt Benckiser spins off its pharmaceutical division

Posted on 29 July 2014

Reckitt Benckiser, the consumer goods giant that makes Nurofen and Dettol, plans to spin off its US-based pharmaceutical business.

Tags: , ,

Galapagos – Rapidly taking identified targets through to clinical development

Posted on 28 July 2014

Galapagos is a clinical stage biotechnology company headquartered in Belgium discovering and developing candidates to phase I/II development.

Tags: , ,

Regenerative medicine: recent partnering deal trends

Posted on 24 July 2014

Regenerative medicine has become increasingly popular in recent years, with the number of deals announced growing steadily

Dermatology partnering – recent deals analysis 2009-2014

Posted on 23 July 2014

Partnering in the last decade has seen an increase in dermatology with an rise specifically in modern diagnostic technologies.

Tags: , ,

Seattle Genetics: Empowering monoclonal antibodies

Posted on 22 July 2014

Seattle Genetics is a biotech company developing and commercializing antibody-based therapeutics to improve the lives of people living with cancer.

Tags: , ,

Seattle Genetics : Biotech industry partnering activity 2009-2014

Posted on 22 July 2014

Seattle Genetics, a successful big biotech industry headquartered in Seattle, focuses its effort on advancing antibody drug conjugate technology targeted toward cancer treatment.

Tags: , ,

Market research analysis: Monoclonal antibody partnering

Posted on 21 July 2014

A recent market research analysis of monoclonal antibody partnering has shown a high interest in partnering deals involving monoclonal antibody technology in the past few years

Tags: , , ,

Galapagos: Biotechnology Partnering activity 2009-2014

Posted on 19 July 2014

Galapagos, a clinical stage biotechnology company in the United States, is a joint venture between Crucell and Tibotec.

Tags: , , , ,

Biotech rumour mill has it that Siemens plans for a spin off

Posted on 15 July 2014

Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division’s IT unit, which could be worth more than $1 billion.

Tags: ,

Spectrum Pharmaceuticals: Partnering activity 2009-2014

Posted on 14 July 2014

Spectrum Pharmaceuticals, headquartered in the United States, showcases in the top 50 big biotech companies.

Tags: , , ,

RSS Feed Linked In Twitter

Latest Tweets